OneSource Specialty Pharma (NSE:ONESOURCE) FCF Margin %: 0.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ONESOURCE OneSource Specialty Pharma Ltd NSE:ONESOURCE
8 GF Score
Price ₹1,483.60
! 3 Warning Signs
View Full Analysis

What is OneSource Specialty Pharma FCF Margin %?

OneSource Specialty Pharma NSE:ONESOURCE -2.14% 8 FCF Margin % is 0.00% as of Jun. 2026. GuruFocus rates NSE:ONESOURCE with a GF Score™ of 8/100. The stock has 3 warning signs investors should review. Among 956 Biotechnology companies, OneSource Specialty Pharma ranks better than 59.31% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. OneSource Specialty Pharma's Free Cash Flow for the three months ended in Jun. 2026 was ₹0 Mil. OneSource Specialty Pharma's Revenue for the three months ended in Jun. 2026 was ₹4,490 Mil. Therefore, OneSource Specialty Pharma's FCF Margin % for the quarter that ended in Jun. 2026 was 0.00%.

As of today, OneSource Specialty Pharma's current FCF Yield % is -3.30%.

The historical rank and industry rank for OneSource Specialty Pharma's FCF Margin % or its related term are showing as below:

NSE:ONESOURCE' s FCF Margin % Range Over the Past 10 Years
Min: -534.07   Med: -69.44   Max: -13.57
Current: -36.32

During the past 4 years, the highest FCF Margin % of OneSource Specialty Pharma was -13.57%. The lowest was -534.07%. And the median was -69.44%.

NSE:ONESOURCE's FCF Margin % is ranked better than
59.31% of 956 companies
in the Biotechnology industry
Industry Median: -80.565 vs NSE:ONESOURCE: -36.32

OneSource Specialty Pharma FCF Margin % Related Terms

OneSource Specialty Pharma FCF Margin % Historical Data

* Premium members only.

The historical data trend for OneSource Specialty Pharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OneSource Specialty Pharma FCF Margin % Chart

OneSource Specialty Pharma Annual Data
Trend Mar23 Mar24 Mar25 Mar26
FCF Margin %
-534.07 -99.45 -13.57 -39.43

OneSource Specialty Pharma Quarterly Data
Mar23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NSE:ONESOURCE vs VRTX, REGN, RVMD: FCF Margin % Comparison

For the Biotechnology subindustry, OneSource Specialty Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OneSource Specialty Pharma FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OneSource Specialty Pharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where OneSource Specialty Pharma's FCF Margin % falls into.


NSE:ONESOURCE
8GF Score
OneSource Specialty Pharma Ltd NSE:ONESOURCE
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OneSource Specialty Pharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

OneSource Specialty Pharma's FCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=-5605.46/14215.9
=-39.43 %

OneSource Specialty Pharma's FCF Margin for the quarter that ended in Jun. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2026 )/Revenue (Q: Jun. 2026 )
=0/4490.23
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
OneSource Specialty Pharma (NSE:ONESOURCE) has a FCF Margin % of 0.00% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on OneSource Specialty Pharma and its competitors. According to the industry distribution chart, OneSource Specialty Pharma ranks #389 out of 956 companies in the Biotechnology industry, placing it in the top 40.7%.
Is OneSource Specialty Pharma's FCF Margin % too high?
OneSource Specialty Pharma's current FCF Margin % is 0.00%. Based on the distribution chart, OneSource Specialty Pharma ranks #389 out of 956 companies in the Biotechnology industry, which is above the industry midpoint. Overall, OneSource Specialty Pharma has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does OneSource Specialty Pharma's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, OneSource Specialty Pharma ranks #389 out of 956 companies for FCF Margin %. This puts OneSource Specialty Pharma in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on OneSource Specialty Pharma and its competitors. OneSource Specialty Pharma's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OneSource Specialty Pharma stock overvalued right now?
OneSource Specialty Pharma (NSE:ONESOURCE) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. OneSource Specialty Pharma's overall GF Score™ is 8/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For OneSource Specialty Pharma (NSE:ONESOURCE), the current FCF Margin % is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OneSource Specialty Pharma Business Description

Other Exchanges 544292:India
Address Bannerghatta Road, Star 1, Opp IIM Bangalore, Bilekahalli, Bangalore, KA, IND, 560076
OneSource Specialty Pharma Ltd is engaged in the research, development, manufacture and commercialization of biological drug products in different injectable formats. The company also offers end-to-end CDMO services across all phases of pre-clinical and clinical development and commercial supply of biologics. The company's reportable segments are CDMO (Contract Development and Manufacturing Organization (CDMO) : Development and manufacture of pharmaceutical products and associated services); and Unit-3 Multimodal Facility and CDMO-2.
8GF Score

Get the complete analysis for NSE:ONESOURCE

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,483.60
Price